top of page
Untitled design (10).png
BANGKOK                -                PHUKET

OUR LAB

INTRODUCING CELL THERAPY AND REGENERATIVE
MEDICINE LABORATORY,

ATGenes Co., Ltd.to Our Site

       At ATGenes Co., Ltd., we have always been driven by a steadfast commitment to advancing the frontiers of molecular genetic testing and healthcare services. Over decade, cell therapy (e.g. stem cells), with their remarkable regenerative potential, have currently emerged as a beacon of hope in the field of healthcare. The Cell Therapy and Regenerative Medicine (CTRM) Laboratory is established since 2018 on the belief that harnessing the unique properties of stem cells can lead to groundbreaking treatments, ultimately improving the lives of patients for a wide array of medical conditions, including degenerative diseases, injuries, and genetic disorders. Through our research and testing, we pave the way for the development of safe and effective cell- based therapies that can transform the lives of patients seeking innovative treatment options.

10 copy.png

       Central to our mission is the pursuit of excellence in cell isolation, expansion, and banking for cell- based therapy purposes. We recognize that the therapeutic promise of cells can be fully realized when we can reliably and efficiently expand these precious cell populations (such as Mesenchymal Stem Cells (MSCs), Natural Killer (NK) Cells etc.) and stored for future uses. Within our state-of-the-art laboratory which following the PICS/GMP (Pharmaceutical Inspection Co-operation Scheme/Good Manufacturing Practice) guideline, we utilize optimized techniques with our high-quality xeno-free growth media formulations (without any component from animals) and equipments to facilitate the robust and scalable growth of cells. Our team of well-trained scientists have also honed their skills to optimize and standardize the expansion processes of various cells types to meet the quality at their clinical applications. This commitment to innovation and quality to ensures that the expanded cells for their safe and effective use in regenerative medicine.

       In addition, at ATGenes Co., Ltd., quality is the cornerstone of our laboratory operations. We understand the critical importance of the quality control (QC) processes of our cell-based product, therefore we adhere our QC testing to the internationally recognized standards/guideline such as ISCT (International Society for Cell and Gene Therapy) guideline and ISO (International Organization for Standardization) 15189:2022 and 15190:2020 standard. Our rigorous QC testings encompass every aspect of cell characterization, including identity, purity, and functionality to ensure the safety and efficacy of our cell-based products..

       Ultimately, the outcomes of our efforts reach well beyond the confines of our laboratory. We are deeply committed to upholding the most rigorous standard operations and standardized quality control testing to ensure that our cell therapy products meet the highest standards before they are deemed suitable for clinical purposes.

OUR QUALITY ASSURANCE

Only the highest standards

QUANTUM FLEX CELL
EXPANSION SYSTEM

First in Asia

Introducing the Next Generation of Cell Expansion device

TEST VARIABLES

REDUCE RISK OF CONTAMINATION

REDUCED SAFETY CONCERNS A

FUNCTIONALLY CLOSED SYSTEM

PROVIDE RESEARCH SCALABILITY

10 copy.png

OUR BACKBONE

Atgenes

Founded in January 2014, ATGenes Co., Ltd. is a biotechnology company crafted by a consortium of medical experts, technologists, and clinical scientists.

 

Pioneering a distinctive business model, this Thai-owned enterprise is dedicated to offering diagnostic and therapeutic services. Specializing in medical devices relying on advanced knowledge-based technology, ATGenes aims to contribute to the bright future of Thailand and global healthcare.

bottom of page